Search by Drug Name or NDC

NDC 76385-0102-01 Primaquine Phosphate 15 mg/1 Details

Primaquine Phosphate 15 mg/1

Primaquine Phosphate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayshore Pharmaceuticals, LLC. The primary component is PRIMAQUINE PHOSPHATE.

MedlinePlus Drug Summary

Primaquine is used alone or with another medication to treat malaria (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) and to prevent the disease from coming back in people that are infected with malaria. Primaquine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.

Related Packages: 76385-0102-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Primaquine

Product Information

NDC	76385-0102
Product ID	76385-102_6b56e67f-8e04-4efd-a12a-4c82596f3adc
Associated GPIs	13000030100310
GCN Sequence Number	009577
GCN Sequence Number Description	primaquine phosphate TABLET 26.3 MG ORAL
HIC3	W4A
HIC3 Description	ANTIMALARIAL DRUGS
GCN	42910
HICL Sequence Number	004148
HICL Sequence Number Description	PRIMAQUINE PHOSPHATE
Brand/Generic	Generic
Proprietary Name	Primaquine Phosphate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Primaquine Phosphate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	15
Active Ingredient Units	mg/1
Substance Name	PRIMAQUINE PHOSPHATE
Labeler Name	Bayshore Pharmaceuticals, LLC
Pharmaceutical Class	Antimalarial [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA204476
Listing Certified Through	2025-12-31

Package

NDC 76385-0102-01 (76385010201)

Pricing Information	N/A
NDC Package Code	76385-102-01
Billing NDC	76385010201
Package	100 TABLET in 1 BOTTLE (76385-102-01)
Marketing Start Date	2014-08-01
NDC Exclude Flag	N